gamma-Aminobutyric acid

From Self-sufficiency
Jump to: navigation, search
gamma-Aminobutyric acid
Simplified structural formula
Ball-and-stick model
style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers
CAS number 56-12-2 YesY
PubChem 119
ChemSpider 116
MeSH gamma-Aminobutyric+Acid
IUPHAR ligand 1067
SMILES Script error: No such module "collapsible list".
style="background: #F8EABA; text-align: center;" colspan="2" | Properties
Molecular formula C4H9NO2
Molar mass 103.12 g/mol
Melting point

203.7 °C, 477 K, 399 °F

 YesY (what is this?)  (verify)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

γ-Aminobutyric acid (GABA) (pronounced /ˈɡæmə əˈmiːnoʊbjuːˈtɪrɨk ˈæsɨd/, or the acronym /ˈɡæbə/) is the chief inhibitory neurotransmitter in the mammalian central nervous system. It plays a role in regulating neuronal excitability throughout the nervous system. In humans, GABA is also directly responsible for the regulation of muscle tone.[1] In insect species GABA acts only on excitatory nerve receptors.

Although chemically it is an amino acid, GABA is rarely referred to as such in the scientific or medical communities, because the term "amino acid," used without a qualifier, refers to the alpha amino acids, which GABA is not, nor is it incorporated into proteins.

In spastic diplegia in humans, GABA absorption becomes impaired by nerves damaged from the condition's upper motor neuron lesion, which leads to hypertonia of the muscles signaled by those nerves that can no longer absorb GABA.



In vertebrates, GABA acts at inhibitory synapses in the brain by binding to specific transmembrane receptors in the plasma membrane of both pre- and postsynaptic neuronal processes. This binding causes the opening of ion channels to allow the flow of either negatively charged chloride ions into the cell or positively charged potassium ions out of the cell. Depending on which ion channels open, the membrane potential is either hyperpolarized or depolarized. This action results in a negative change in the transmembrane potential, usually causing hyperpolarization. Two general classes of GABA receptor are known: GABAA in which the receptor is part of a ligand-gated ion channel complex, and GABAB metabotropic receptors, which are G protein-coupled receptors that open or close ion channels via intermediaries (G proteins).

The production, release, action and degradation of GABA at a stereotyped GABAergic synapse
Neurons that produce GABA as their output are called GABAergic neurons, and have chiefly inhibitory action at receptors in the adult vertebrate. Medium Spiny Cells are a typical example of inhibitory CNS GABAergic cells. In contrast, GABA exhibits excitatory actions in insects, mediating muscle activation at synapses between nerves and muscle cells, and also the stimulation of certain glands. In mammals, some GABAergic neurons, such as chandelier cells, are also able to excite their glutamatergic counterparts.[2]

GABAA receptors are chloride channels; that is, when activated by GABA, they allow the flow of chloride ions across the membrane of the cell. Whether this chloride flow is excitatory/depolarizing (makes the voltage across the cell's membrane less negative), shunting (has no effect on the cell's membrane) or inhibitory/hyperpolarizing (makes the cell's membrane more negative) depends on the direction of the flow of chloride. When net chloride flows out of the cell, GABA is excitatory or depolarizing; when the net chloride flows into the cell, GABA is inhibitory or hyperpolarizing. When the net flow of chloride is close to zero, the action of GABA is shunting. Shunting inhibition has no direct effect on the membrane potential of the cell, however it minimises the effect of any coincident synaptic input essentially by reducing the electrical resistance of the cell's membrane (essentially equivalent to Ohm's law). A developmental switch in the molecular machinery controlling concentration of chloride inside the cell and hence the direction of this ion flow, is responsible for the changes in the functional role of GABA between the neonatal and adult stages. That is to say, GABA's role changes from excitatory to inhibitory as the brain develops into adulthood.[3]


In hippocampus and neocortex of the mammalian brain, GABA has primarily excitatory effects early in development, and is in fact the major excitatory neurotransmitter in many regions of the brain before the maturation of glutamate synapses - See developing cortex.[3]

In the developmental stages preceding the formation of synaptic contacts, GABA is synthesized by neurons and acts both as an autocrine (acting on the same cell) and paracrine (acting on nearby cells) signalling mediator.[4][5]

GABA regulates the proliferation of neural progenitor cells[6][7] the migration[8] and differentiation[9][10] the elongation of neurites[11] and the formation of synapses.[12]

GABA also regulates the growth of embryonic and neural stem cells. GABA can influence the development of neural progenitor cells via brain-derived neurotrophic factor (BDNF) expression.[13] GABA activates the GABAA receptor, causing cell cycle arrest in the S-phase, limiting growth.[14]

Beyond the nervous system

File:PMID19190758 PLoS 0004371.png
GABA-producing GAD67 enzyme in the brain slice at 1st postnatal day, with the highest expression in subventricular zone (svz). From Popp et al., 2009.[15]
GABAergic mechanisms have been demonstrated in various peripheral tissues and organs including, but not restricted to the intestine, stomach, pancreas, Fallopian tube, uterus, ovary, testis, kidney, urinary bladder, lung and liver.[16]

In 2007, an excitatory GABAergic system was described in the airway epithelium. The system activates following exposure to allergens and may participate in the mechanisms of asthma.[17] GABAergic systems have also been found in the testis[18] and in the eye lens.[19]

Structure and conformation

GABA is found mostly as a zwitterion, that is, with the carboxy group deprotonated and the amino group protonated. Its conformation depends on its environment. In the gas phase, a highly folded conformation is strongly favored because of the electrostatic attraction between the two functional groups. The stabilization is about 50 kcal/mol, according to quantum chemistry calculations. In the solid state, a more extended conformation is found, with a trans conformation at the amino end and a gauche conformation at the carboxyl end. This is due to the packing interactions with the neighboring molecules. In solution, five different conformations, some folded and some extended are found as a result of solvation effects. The conformational flexibility of GABA is important for its biological function, as it has been found to bind to different receptors with different conformations. Many GABA analogues with pharmaceutical applications have more rigid structures in order to control the binding better.[20][21]


Gamma-aminobutyric acid was first synthesized in 1883,[citation needed] and was first known only as a plant and microbe metabolic product. In 1950, however, GABA was discovered to be an integral part of the mammalian central nervous system.[22]


Since GABA doesn't penetrate the blood brain barrier, GABA is therefore synthesized in vivo. It's synthesized from glutamate using the enzyme L-glutamic acid decarboxylase and pyridoxal phosphate (which is the active form of vitamin B6) as a cofactor via a metabolic pathway called the GABA shunt. This process converts glutamate, the principal excitatory neurotransmitter, into the principal inhibitory neurotransmitter (GABA).[23][24]


Drugs that act as agonists of GABA receptors (known as GABA analogues or GABAergic drugs) or increase the available amount of GABA typically have relaxing, anti-anxiety and anti-convulsive effects.[25],[26]. Many of the substances below are known to cause anterograde amnesia and retrograde amnesia.

In general, GABA does not cross the blood-brain barrier,[27] although certain areas of the brain which have no effective blood brain barrier, such as the periventricular nucleus, can be reached by drugs such as systematically injected GABA.[28] At least one study suggests that orally administered GABA increases the amount of Human Growth Hormone.[29] GABA directly injected to the brain has been reported to have both stimulatory and inhibitory effects on the production of growth hormone, depending on the physiology of the individual.[28]

GABAergic Drugs

See also


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

  • Lydiard B, Pollack MH, Ketter TA, Kisch E, Hettema JM (2001-10-26). "GABA". Continuing Medical Education. School of Medicine, Virginia Commonwealth University, Medical College of Virginia Campus (VCU), Richmond, VA. Retrieved 2008-06-20. The role of GABA in the pathogenesis and treatment of anxiety and other neuropsychiatric disorders 
  • Scholarpedia article on GABA
ca:Àcid γ-aminobutíric

cs:Kyselina gama-aminomáselná da:GABA de:Γ-Aminobuttersäure et:Γ-aminovõihape es:Ácido γ-aminobutírico eo:Gamo-Aminobuteracido fr:Acide γ-aminobutyrique ko:감마 아미노낙산 id:Asam gamma-aminobutirat it:Acido γ-amminobutirrico he:GABA hu:Gamma-amino-vajsav nl:Gamma-aminoboterzuur ja:Γ-アミノ酪酸 no:GABA pl:Kwas γ-aminomasłowy pt:Ácido gama-aminobutírico ru:Гамма-аминомасляная кислота simple:Gamma-Aminobutyric acid sk:Kyselina gama-aminomaslová sl:Γ-aminomaslena kislina fi:Gamma-aminovoihappo sv:GABA ta:காமா அமினோ புயூட்டைரிக் காடி tr:Gamma aminobütirik asit uk:Гамма-аміномасляна кислота

  1. Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H (2002). "GABA and GABA receptors in the central nervous system and other organs". Int. Rev. Cytol. 213: 1–47. doi:10.1016/S0074-7696(02)13011-7. PMID 11837891. 
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. 3.0 3.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  4. Purves D, Fitzpatrick D, Hall WC, Augustine GJ, Lamantia A-S (2007). Neuroscience (4th ed.). Sunderland, Mass: Sinauer. pp. 135, box 6D. ISBN 0-87893-697-1. 
  5. Jelitai M, Madarasz E (2005). "The role of GABA in the early neuronal development" ([dead link]). Int. Rev. Neurobiol. 71: 27–62. doi:10.1016/S0074-7742(05)71002-3. PMID 16512345. 
  6. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  7. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  8. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  9. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  10. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  11. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  12. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  13. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  14. Wang DD, Kriegstein AR, Ben-Ari Y (2008). "GABA Regulates Stem Cell Proliferation before Nervous System Formation". Epilepsy currents / American Epilepsy Society. 8 (5): 137–9. doi:10.1111/j.1535-7511.2008.00270.x. PMC 2566617Freely accessible. PMID 18852839. 
  15. Popp A, Urbach A, Witte OW, Frahm C (2009). "Adult and embryonic GAD transcripts are spatiotemporally regulated during postnatal development in the rat brain". PLoS ONE. 4 (2): e4371. doi:10.1371/journal.pone.0004371. PMC 2629816Freely accessible. PMID 19190758. 
  16. Erdö SL, Wolff JR (1990). "gamma-Aminobutyric acid outside the mammalian brain". J. Neurochem. 54 (2): 363–72. doi:10.1111/j.1471-4159.1990.tb01882.x. PMID 2405103. 
  17. Xiang, Y.; Wang, S.; Liu, M.; Hirota, J.; Li, J.; Ju, W.; Fan, Y.; Kelly, M.; Ye, B. (2007). "A GABAergic system in airway epithelium is essential for mucus overproduction in asthma". Nature medicine. 13 (7): 862–867. doi:10.1038/nm1604. PMID 17589520.  edit
  18. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  19. Kwakowsky, A.; Schwirtlich, M.; Zhang, Q.; Eisenstat, D.; Erdélyi, F.; Baranyi, M.; Katarova, Z.; Szabó, G. (2007). "GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5". Developmental dynamics : an official publication of the American Association of Anatomists. 236 (12): 3532–3544. doi:10.1002/dvdy.21361. PMID 17969168.  edit
  20. Devashis Majumdar and Sephali Guha.(1988). "Conformation, electrostatic potential and pharmacophoric pattern of GABA (gamma-aminobutyric acid) and several GABA inhibitors." Journal of Molecular Structure: THEOCHEM 180: 125-140. doi:10.1016/0166-1280(88)80084-8
  21. Anne-Marie Sapse. Molecular Orbital Calculations for Amino Acids and Peptides. Birkhäuser, 2000. ISBN 0817638938.
  22. Roth, Robert J.; Cooper, Jack R.; Bloom, Floyd E. (2003). The Biochemical Basis of Neuropharmacology. Oxford [Oxfordshire]: Oxford University Press. pp. 416 pages. ISBN 0-19-514008-7. 
  23. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  24. Schousboe A, Waagepetersen HS (2007). "GABA: homeostatic and pharmacological aspects". Prog. Brain Res. 160: 9–19. doi:10.1016/S0079-6123(06)60002-2. PMID 17499106. 
  25. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  26. Chapouthier, G, Venault P., A pharmacological link between epilepsy and anxiety ?, Trends in Pharmacological Sciences, 2001, 22(10), 491-493}}
  27. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  28. 28.0 28.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found. Free full-text.
  29. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  30. Dzitoyeva S, Dimitrijevic N, Manev H (2003). "Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence". Proc. Natl. Acad. Sci. U.S.A. 100 (9): 5485–90. doi:10.1073/pnas.0830111100. PMC 154371Freely accessible. PMID 12692303. 
  31. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL (1997). "Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors". Nature. 389 (6649): 385–9. doi:10.1038/38738. PMID 9311780. 
  32. Boehm SL, Ponomarev I, Blednov YA, Harris RA (2006). "From gene to behavior and back again: new perspectives on GABAAreceptor subunit selectivity of alcohol actions". Adv. Pharmacol. 54: 171–203. doi:10.1016/j.bcp.2004.07.023. PMID 17175815. 
  33. Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H (2005). "Drosophila GABAB receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB)". Eur. J. Pharmacol. 519 (3): 246–52. doi:10.1016/j.ejphar.2005.07.016. PMID 16129424. 
  34. "Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity". Retrieved 2010-03-08.